Pfizer GCP Training Sample Clauses
The "Pfizer GCP Training" clause requires that individuals involved in a clinical trial or research project complete Good Clinical Practice (GCP) training as specified by Pfizer. This typically means that all study staff must undergo and maintain up-to-date certification in GCP standards, which may involve completing online modules or in-person sessions approved by Pfizer. The core function of this clause is to ensure that all personnel adhere to internationally recognized ethical and scientific quality standards, thereby safeguarding participant safety and data integrity throughout the study.
POPULAR SAMPLE Copied 1 times
Pfizer GCP Training. Prior to enrollment of any Study Subjects (as defined in Section 4, Subject Enrollment), Principal Investigator and any sub-investigators will complete the Pfizer-provided Good Clinical Practice training course (“Pfizer GCP Training”). Any investigators who later join the Study will complete the Pfizer GCP Training before performing Study-related duties. For studies of applicable duration, Principal Investigator and sub-investigators will complete Pfizer GCP Training every three years during the term of the Study, or more often if there are significant changes to the ICH GCP guidelines or course materials.
Pfizer GCP Training. Prior to enrollment of any Study Subjects (as defined in Section 4, Subject Enrollment), Principal Investigator and any sub-investigators will complete the Pfizer-provided Good Clinical Practice training course (“Pfizer GCP Training”). Any investigators who later join the Study will complete the Pfizer GCP Training before performing Study-related duties. For studies of applicable duration, Principal Investigator and sub-investigators will complete Pfizer GCP Training every three years during the term of the Study, or more often if there are significant changes to the ICH GCP guidelines or course 1.3 Školení správné klinické praxe (GCP) poskytované společností Pfizer. Před tím, než dojde k zařazení subjektů do Studie (definovaném v článku 4, Zařazení subjektů) absolvují Hlavní zkoušející a všichni spoluzkoušející školení správné klinické praxe poskytované společností Pfizer (dále jen „školení GCP společnosti Pfizer“). Všichni zkoušející, kteří se do Studie zapojí později, absolvují školení GCP společnosti Pfizer před tím, než začnou vykonávat povinnosti související se Studií. U dlouhodobých studií absolvují Hlavní zkoušející a všichni spluzkoušející školení materials. GCP společnosti Pfizer každé tři roky po dobu trvání Studie nebo i častěji, jestliže dojde k významným změnám v pokynech ICH GCP nebo v materiálech školení.
Pfizer GCP Training. Any investigators who later join the Study will complete the Pfizer GCP Training before performing Study-related duties. For studies of applicable duration, Principal Investigator and sub-investigators will complete Pfizer GCP Training every three years during the term of the Study, or more often if
Pfizer GCP Training. Principal Investigator and any sub-investigators listed on Form FDA 1572 Statement of Investigator as “SubInvestigators” will complete a Pfizer- provided Good Clinical Practice training course (“Pfizer GCP Training”) before
Pfizer GCP Training. Principal Investigator and any sub-investigators listed on Form FDA 1572 Statement of Investigator as “SubInvestigators” will complete a Pfizer-provided Good Clinical Practice training course (“Pfizer GCP Training”) before enrollment of any Study Subjects (as defined in Section 5, Subject Enrollment) in a Study. Any investigators who later join the Study will complete the Pfizer GCP Training before performing Study-related duties. For studies of applicable duration, Principal Investigator and sub-investigators will complete Pfizer GCP Training every three years during the term of the Study, or more often if there are significant changes to the ICH GCP guidelines or course materials.
Pfizer GCP Training. Prior to 5ale5ment of any Study Subjects (as defined in Section 4, Subject Enrollment), the Health Services Provider’s Principal Investigator and any sub-investigators will complete the Pfizer-provided Good Clinical Practice training course (“Pfizer GCP Training”). Any investigators who later join the Study will complete the Pfizer GCP Training before performing Study-related duties. For studies of applicable duration,